Picker Chosen by Lymphoma Coalition to Conduct their 10th Global Survey on Lymphomas & CLL

Leading health and social care charity Picker has been appointed by Lymphoma Coalition to lead its 10^th Global Patient Survey (GPS) on Lymphomas and Chronic Lymphocytic Leukemia (CLL) in 2026. The GPS has achieved 50,000+ responses from 80+ countries since it was launched in 2008. 

The primary goal with this survey is to better understand the lived experiences of lymphoma and CLL and the effects of treatment and care. These insights are vital in shaping actions and support that truly reflect patient needs around the world.

Key findings uncovered in the 2024 GPS included: 

• One third of respondents (33%) did not receive a correct first diagnosis;  

• 4 in 10 patients (41%) experienced a barrier to treatment and; 

• 94% of patients experienced physical side effects from their treatment. 

Launching on Monday 19^th January 2026, the GPS is open to adults aged 18 years and over who have been diagnosed with lymphoma or CLL (a subtype of lymphoma), or for people who care for someone who has lymphoma or CLL. It will be distributed online in 21 languages, ensuring an inclusive approach to gathering insights from a diverse global population. 

Picker, with its extensive experience conducting Global Patient Surveys, is proud to partner with Lymphoma Coalition to deliver this significant milestone of their 10^th Global Patient Survey on Lymphomas and CLL. 

Sarah Gunn, Senior Project Manager at Picker, said:  

“Picker is dedicated to listening to patients and care partners experiences. Together, with Lymphoma Coalition, we aim to transform these experiences into lasting improvements in lymphoma and CLL care.”

Lorna Warwick, CEO of Lymphoma Coalition, said:  

“The data from this survey is more than numbers, it’s a catalyst for change. It guides policy, strengthens advocacy, and ensures that patient experiences shape resources, research, and awareness campaigns that improve lymphoma care globally.” 

– Ends –

Notes to editors

• For media enquiries, please contact Picker’s Marketing and Communications team at [email protected], or phone: 01865 632 235.
• Further details about the Lymphoma Coalition Global Patient Survey are available on their website. 
• Picker is an international charity working across health and social care. Established in the US in 1987 and UK in 2000, our work is at the forefront of understanding and furthering the link between patient experience, person centred care, and clinical excellence.  We believe in high quality person centred care for all, always.  
• Picker’s team of researchers and data scientists are available to support organisations in understanding, measuring, and using workforce and user experience. For queries about our services or to request a call, please contact [email protected].